147 related articles for article (PubMed ID: 24786602)
1. Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS.
Ruf CG; Schmelz HU; Port M; Wagner W; Matthies C; Müller-Myhsok B; Meineke V; Abend M
Br J Cancer; 2014 May; 110(11):2738-46. PubMed ID: 24786602
[TBL] [Abstract][Full Text] [Related]
2. Small RNAs in the peripheral blood discriminate metastasized from non-metastasized seminoma.
Ruf CG; Dinger D; Port M; Schmelz HU; Wagner W; Matthies C; Müller-Myhsok B; Meineke V; Abend M
Mol Cancer; 2014 Mar; 13():47. PubMed ID: 24597607
[TBL] [Abstract][Full Text] [Related]
3. Clinically apparent and occult metastasized seminoma: almost indistinguishable on the transcriptional level.
Ruf CG; Port M; Schmelz HU; Wagner W; Müller F; Senf S; Matthies C; Müller-Myhsok B; Meineke V; Abend M
PLoS One; 2014; 9(5):e95009. PubMed ID: 24788992
[TBL] [Abstract][Full Text] [Related]
4. Predicting metastasized seminoma using gene expression.
Ruf CG; Linbecker M; Port M; Riecke A; Schmelz HU; Wagner W; Meineke V; Abend M
BJU Int; 2012 Jul; 110(2 Pt 2):E14-20. PubMed ID: 22243760
[TBL] [Abstract][Full Text] [Related]
5. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
6. Testicular cancer: identifying occult metastatic seminoma using two small RNAs.
Payton S
Nat Rev Urol; 2014 Jun; 11(6):306. PubMed ID: 24861326
[No Abstract] [Full Text] [Related]
7. Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.
Lewin J; Soltan Ghoraie L; Bedard PL; Hamilton RJ; Chung P; Moore M; Jewett MAS; Anson-Cartwright L; Virtanen C; Winegarden N; Tsao J; Warde P; Sweet J; Haibe-Kains B; Hansen AR
BJU Int; 2018 Nov; 122(5):814-822. PubMed ID: 29726090
[TBL] [Abstract][Full Text] [Related]
8. OCT4 staining increases the detection of lymphatic/vascular invasion in pure seminoma of the testis obscured by prominent lymphohistiocytic inflammation.
Renshaw AA; Gould EW
Pathology; 2016 Apr; 48(3):210-3. PubMed ID: 27020494
[TBL] [Abstract][Full Text] [Related]
9. Regulation network analysis of testicular seminoma at various stages of progression.
Sha JJ; Dong YH; Liu DM; Bo JJ; Huang YR; Li Z; Ping P
Genet Mol Res; 2013 Mar; 12(4):4297-307. PubMed ID: 23546980
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinical metastasis at diagnosis of testicular seminoma.
Gallegos I; Valdevenito JP; Miranda R; Fernandez C
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):147-52. PubMed ID: 20881837
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumors.
Baou N; Bouras M; Droz JP; Dutrieux-Berger N; Bouvier R; Benahmed M; Krantic S
Cancer Detect Prev; 2001; 25(5):446-53. PubMed ID: 11718451
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic dilemma in a man with seminoma.
Klümpen HJ; Westermann AM
Lancet; 2004 Dec 18-31; 364(9452):2230. PubMed ID: 15610813
[No Abstract] [Full Text] [Related]
14. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
15. Metastatic seminomas in lymph nodes: CD10 immunoreactivity can be a pitfall of differential diagnosis.
Ota Y; Iihara K; Ryu T; Morikawa T; Fukayama M
Int J Clin Exp Pathol; 2013; 6(3):498-502. PubMed ID: 23411938
[TBL] [Abstract][Full Text] [Related]
16. Testicular seminoma presenting with features of androgen excess.
Fung LC; Honey RJ; Gardiner GW
Urology; 1994 Dec; 44(6):927-9. PubMed ID: 7985328
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Significance of Seminoma Component in Testicular Mixed Germ Cell Tumour.
Akan S; Ediz C; Tavukcu HH; Ozgun A; Yilmaz O
Urol Int; 2020; 104(5-6):489-496. PubMed ID: 32241010
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features predicting nodal metastasis of testicular seminoma: results from 100 cases in a single institute.
Sato A; Ohigashi T; Oya M; Nakashima J; Marumo K; Murai M
Urol Int; 2006; 77(1):64-8. PubMed ID: 16825818
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of primary testicular seminoma: a report on 57 new cases.
Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
[TBL] [Abstract][Full Text] [Related]
20. Delayed presentation of primary testicular seminoma.
Capp AL; Kearsley JH
Australas Radiol; 1998 Aug; 42(3):213-5. PubMed ID: 9727244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
